What is Genevive?
Genevive operates at the intersection of primary care and geriatric medicine, providing comprehensive health management for older adults residing in assisted living and long-term care facilities. The company distinguishes itself through a model of board-certified provider oversight and personalized care coordination, which is designed to align medical treatment with the specific goals of patients and their families. By integrating transitional care services for those recovering from acute illnesses, Genevive addresses the complex clinical needs of an aging population, effectively reducing hospital readmissions and improving overall quality of life metrics within the senior care ecosystem.
How much funding has Genevive raised?
Genevive has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Genevive
PPP
Public-Private Partnership
What's next for Genevive?
With this major strategic investment, Genevive is well-positioned to scale its operational footprint and enhance its care coordination infrastructure. The company is expected to leverage this capital to expand its network of board-certified providers and deepen its integration with insurance programs, thereby strengthening its market position. As the demand for specialized geriatric services continues to rise, Genevive's focus on data-driven, compassionate care will likely serve as a catalyst for further growth and potential partnerships within the broader healthcare technology and services market. Future initiatives will likely center on optimizing patient outcomes through advanced care management protocols and expanding service delivery across additional assisted living facilities.
See full Genevive company page
